平成10年
Rosenberg SA, Yang J, Schwartzentruber D, Hwu P, Marincola F, Topalian S, Restifo N, Dudley M, Schwarz S, Spiess P, Wunderlich J, Parkhurst M, Kawakami Y, Seipp C, Einhorn J and White D. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med.4(3):321-327.1998 Mar
Kawakami Y, Robbins PF, Wang RF, Parkhurst M, Kang X and Rosenberg SA. The use of melanosomal proteins in the immunotherapy of melanoma. J Immunother.21(4):237-246.1998 Jul
Parkhurst M, Fitzgerald E, Southwood S, Sette A, Rosenberg SA and Kawakami Y. Identification of a shared HLA-A*0201 restricted T cell epitope from the melanoma antigen tyrosinase related protein 2 (TRP2). Cancer Res.58(21):4895-4901.1998 Nov
Kawakami Y, Robbins PF, Wang X, Tupesis JP, Parkhurst MR, Kang X, Kazuyasu K, Appella E and Rosenberg SA. Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles. J Immunol.161(12):6985-6992.1998 Dec
Kawakami Y. Immunotherapy using T cell defined tumor antigens for melanoma. Microbiol. Immunol.42(12):803-813.1998